References

1. Vasilevskii I.V. Kliniko–farmakologicheskie podkhody k primeneniyu sovremennykh nesteroidnykh protivovospalitel‘nykh sredstv [Clinico-pharmacological approaches to the use of modern NSAIDs]. Materialy nauchno-prakticheskoi konferentsii GKB g. Minska [Proc. of Sci. Conf. City Clinical Hospital of Minsk]. Minsk, 2010, p. 6.

2. Veber V.R., Moroz B.T. Klinicheskaya farmakologiya dlya stomatologov [Clinical Pharmacology for dentists]. St. Petersburg, 2003, p. 352.
3. Grudyanov A.I., Dmitrieva L.A., Maksimovskii Yu.M. Parodontologiya. Sovremennoe sostoyanie voprosa i napravlenie nauchnykh razrabotok [Parodontics. The current state of the question and the direction of scientific development]. Stomatologiya [Stomatology], 1999, no. 1, pp. 16–21.
4. Dubikov A.I. Nesteroidnye protivovospalitel’nye preparaty: vozvrashchayas’ k osnovam [Nonsterodal anti-inflammatory drags: back to basics]. Meditsinskii sovet [Medical Council], 2008, 5–6, pp. 61–65.
5. Epifanova Yu.V., Khitrov V.Yu. Otsenka urovnei bioaminov v krovi u bol’nykh khronicheskim parodontitom na fone infuzionnoi terapii [Evaluation bioamines levels in the blood in patients with chronic periodontitis in the background]. Vestnik RUDN. Ser. Meditsina [RUDN-University Bulletin. Medicine], 2009, no. 4, pp. 395–397.
6. Zoryan E.V., Rabinovich S.A. Nesteroidnye protivovospalitel’nye preparaty: kriterii vybora effektivnoi i bezopasnoi terapii [Nonsteroidal anti-inflammatory drags: the criteria for selecting an effective and safe therapy]. Meditsinskii alfavit [Medical alphabet], 2012, vol. 3, no. 13, pp. 52–54.
7. Kulazhenko V.I. Effektivnost’ lechebno-profilakticheskikh meropriyatii pri zabolevaniyakh parodonta u podrostkov: avtoref. dis. … kand. med. nauk [The effectiveness of therapeutic and preventive measures in periodontal diseases in adolescents. Abstract of PhD thesis]. Moscow, 1987, 23 p.
8. Samigullina L.I. Farmakoepidemicheskii analiz ambulatornykh naznachenii NPVS v khirurgicheskoi stomatologii [Pharmaco epidemic analysis of outpatient prescriptions of NSAIDs in surgical dentistry]. Fundamental Research, 2012, no. 4, pp. 112–115.
9. Shostak N.A., Anichkov D.A. Nesteroidnye protivovospalitel’nye preparaty i kardiovaskulyarnyi risk [Nonsteroidal anti-inflammatory drags and cardiovascular risk]. Klinitsist [Clinician], 2008, no. 2, pp. 4–5.
10. Shchekina E.G. Mekhanizmy deistviya i primenenie sovremennykh NPVS [Mechanisms of action and the use of modern NSAIDs]. Provizor [Pharmacist], 2007, no. 11, pp. 38–41.
11. Cross S.A., Ewen S.W., Rost F.V. A study of methods available for cytochemical localization of histamine by fluorescence induced with o-phtaldehde or acetaldehyde. Histochem., 1971, vol. 3, no. 6, pp. 471–476.
12. Falck B., Hillarp N.A., Thieme G., Torp A. Fluorescence of catecholamines and related compounds condensed with formaldehyde. Histochem. Cytochem., 1962, vol. 10, pp. 348–354.
13. Herrera B.S., Coimbra L.S., da Silva A.R., Teixeira S.A., Costa S.K., Wallace J.L., Spolidorio L.C., Muscara M.N. The H2S-releasing naproxen derivative, ATB-346, inhibits alveolar bone loss and inflammation in rats with ligature-induced periodontitis. Med Gas Res., 2015,, vol. 5, no. 4, pp. 13618–13625.
14. Kassem AA, Ismail F.A, Naggar V.F, Aboulmagd E. Comparative study to investigate the effect of meloxicam or minocycline HCl in situ gel system on local treatment of periodontal pockets. AAPS PharmSciTech., 2014, Aug., no. 4, pp. 1021–1028.
15. Materazzi S., Nassini R., Andre E. et al. Cox-dependent fatty acid metabolites cause pain through activation of the irritant receptor TRPA1. PNAS, 2008, vol. 105, no. 33, pp. 12045–12050.
16. Saxer U.P., Mühlemann H.R. Motivation and Aufklärung. Schweiz Monatsschr Zahnheilk, 1975, no. 85, pp. 905–919.
17. Vardar S, Baylas H, Huseyinov А. Effects of selective cyclooxygenase-2 inhibition on gingival tissue levels of prostaglandin E2 and prostaglandin F2alpha and clinical parameters of chronic periodontitis. Periodontol., 2003, Jan., vol. 74, no. 1, pp. 57–63.